Wall Street Associates’s Dare Bioscience DARE Stock Holding History

Wall Street Associates’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-3,958	Closed	-$1.74M	–	305
2015 Q3	$1.74M	Hold	3,958	–	–	0.33%	92
2015 Q2	$2.19M	Hold	3,958	–	–	0.21%	122
2015 Q1	$4.28M	Hold	3,958	–	–	0.4%	90
2014 Q4	$2.95M	Hold	3,958	–	–	0.28%	111
2014 Q3	$2M	Hold	3,958	–	–	0.21%	134
2014 Q2	$2.75M	Buy	+3,958	New	+$3.05M	0.24%	132

Other funds holding DARE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

PVMCI

Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Wall Street Associates's DARE Position: Q4 2015 in Review

Wall Street Associates sold out of Dare Bioscience (DARE) in Q4 2015, closing a stake of 3,958 shares — an estimated $1.74M sold.

Wall Street Associates first reported a position in DARE in Q2 2014 and held it in 6 quarters. The position peaked at $4.28M in Q1 2015. 37 funds tracked by Wall St. Rank hold DARE as of Q4 2015.

Wall Street Associates reported no remaining Dare Bioscience position as of Q4 2015 after selling out during the quarter.
Wall Street Associates sold 3,958 Dare Bioscience shares in Q4 2015, an estimated $1.74M.
Wall Street Associates first reported a position in Dare Bioscience in Q2 2014 and held it in 6 quarters.
Wall Street Associates's Dare Bioscience position peaked at $4.28M in Q1 2015.
37 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2015.

Based on Wall Street Associates's 13F filing for Q4 2015, filed 11 Feb 2016.